Incidence of primary hepatitis C infection and risk factors for transmission in an Australian prisoner cohort

BMC Public Health

Volumn 10, Issue , 2010, Pages

  Teutsch, Suzy ^a   Luciani, Fabio ^a   Scheuer, Nicolas ^b   McCredie, Luke ^c   Hosseiny, Parastu ^a   Rawlinson, William ^d   Kaldor, John ^e   Dore, Gregory J ^e   Dolan, Kate ^b   Ffrench, Rosemary ^f   Lloyd, Andrew ^a   Haber, Paul ^g   Levy, Michael ^h  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c Justice Health Centre for Health Research in Criminal Justice   (Australia)

^d PRINCE OF WALES HOSPITAL   (Australia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f BURNET INSTITUTE   (Australia)

^g ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^h AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AUSTRALIA; COHORT ANALYSIS; DISEASE TRANSMISSION; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INTERVIEW; LONGITUDINAL STUDY; MALE; PRIMARY PREVENTION; PRISONER; RISK FACTOR;

ADULT; COHORT STUDIES; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERVIEWS AS TOPIC; LONGITUDINAL STUDIES; MALE; NEW SOUTH WALES; PRIMARY PREVENTION; PRISONERS; RISK FACTORS; YOUNG ADULT;

EID: 77958072659     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-10-633     Document Type: Article

References (38)

1. Epidemiology of hepatitis C in the West. MJ Alter, Semin Liver Dis 1995 15 1 5 14 10.1055/s-2007-1007259 7597444
2. Global burden of disease (GBD) for hepatitis C. The Global Burden Of Hepatitis C WG, J Clinical Pharmacol 2004 44 1 20 29 10.1177/0091270003258669 (Pubitemid 38005090)
3. Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland. SA Villano D Vlahov KE Nelson CM Lyles S Cohn DL Thomas, J Clin Microbiol 1997 35 12 3274 3277 9399533
4. High hepatitis C incidence in new injecting drug users: a policy failure? L Maher J Li B Jalaludin KG Chant JM Kaldor, ANZJ Public Health 2007 31 1 30 35
5. Viral hepatitis in incarcerated adults: a medical and public health concern. DR Hunt S Saab, Am J Gastroenterol 2009 104 4 1024 1031 10.1038/ajg.2008.143 19240708
6. The 2001 New South Wales Inmate Health Survey. Corrections Health Service. Sydney. ISBN: 0 7347 3560 X. T Butler L Milne, http://www. justicehealth.nsw.gov.au/publications/Inmate-Health-Survey-2001.pdf
7. Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study. I van Beek R Dwyer GJ Dore K Luo JM Kaldor, BMJ 1998 317 7156 433 437 9703523
8. Hepatitis C virus infection in South Australian prisoners: seroprevalence, seroconversion, and risk factors. ER Miller P Bi P Ryan, Int J Infect Dis 2009 13 2 201 208 10.1016/j.ijid.2008.06.011 18790659
9. 1995 Inmate Health Survey. Final report. Correctional, Service, Canada, Ottawa, The Service, Correctional Research and Development 1996
10. Drug injection and HIV prevalence in inmates of Glenochil prison. SM Gore AG Bird SM Burns DJ Goldberg AJ Ross J Macgregor, BMJ 1995 310 6975 293 296 7866170
11. Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons. GE Macalino D Vlahov S Sanford-Colby S Patel K Sabin C Salas JD Rich, Am J Public Health 2004 94 7 1218 1223 10.2105/AJPH.94.7.1218 15226146
12. Community incidence of hepatitis B and C among reincarcerated women. GE Macalino D Vlahov BP Dickinson B Schwartzapfel JD Rich, Clin Infect Dis 2005 41 7 998 1002 10.1086/432936 16142665
13. Spread of bloodborne viruses among Australian prison entrants. N Crofts T Stewart P Hearne XY Ping AM Breshkin SA Locarnini, BMJ 1995 310 6975 285 288 7866168
14. Incidence of hepatitis C virus infection and associated risk factors among Scottish prison inmates: a cohort study. JK Champion A Taylor S Hutchinson S Cameron J McMenamin A Mitchell D Goldberg, Am J Epidemiol 2004 159 5 514 519 10.1093/aje/kwh061 14977648
15. Prevalence and incidence of bloodborne viral infections among Danish prisoners. PB Christensen HB Krarup HG Niesters H Norder J Georgsen, Eur J Epidemiol 2000 16 11 1043 1049 10.1023/A:1010833917242 11421474
16. A randomised controlled trial of methadone maintenance treatment versus wait list control in an Australian prison system. KA Dolan J Shearer M MacDonald RP Mattick W Hall AD Wodak, Drug & Alcohol Depend 2003 72 1 59 65
17. Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection. KA Dolan J Shearer B White J Zhou J Kaldor AD Wodak, Addiction 2005 100 6 820 828 10.1111/j.1360-0443.2005.01050.x 15918812
18. Prisoners are at risk for hepatitis C transmission. T Butler A Kariminia M Levy J Kaldor, Eur J Epidemiol 2004 19 12 1119 1122 10.1007/s10654-004-1705-9 15678792
19. Prevalence and incidence of hepatitis C virus infection among male prison inmates in Maryland. D Vlahov KE Nelson TC Quinn N Kendig, Eur J Epidemiol y 1993 9 5 566 569
20. Hepatitis C transmission and HIV post-exposure prophylaxis after needle- and syringe-sharing in Australian prisons. BG O'Sullivan MH Levy KA Dolan JJ Post SG Barton DE Dwyer JM Kaldor AE Grulich, Med J Aust 2003 178 11 546 549 12765501
21. Correlates of hepatitis C virus seropositivity in prison inmates: a meta-analysis. MF Vescio B Longo S Babudieri G Starnini S Carbonara G Rezza R Monarca, J Epidemiol & Commun Health 2008 62 4 305 313
22. Clearance of hepatitis C viremia associated with cellular immunity in the absence of seroconversion in the hepatitis C incidence and transmission in prisons study cohort. JJ Post Y Pan AJ Freeman CE Harvey PA White P Palladinetti PS Haber G Marinos MH Levy JM Kaldor,, et al. J Infect Dis 2004 189 10 1846 1855 10.1086/383279 15122521
23. D Clayton M Hills, Statistical models in epidemiology Oxford, UK: Oxford University Press 1993
24. Detection of hepatitis C core antigen in the antibody negative 'window' phase of hepatitis C infection. J Peterson G Green K Iida B Caldwell P Kerrison S Bernich K Aoyagi SR Lee, Vox Sang 2000 78 2 80 85 10.1046/j.1423-0410.2000. 7820080.x 10765142
25. Testing strategy to identify cases of acute hepatitis C virus (HCV) infection and to project HCV incidence rates. K Page-Shafer BL Pappalardo LH Tobler BH Phelps BR Edlin AR Moss TL Wright DJ Wright TR O'Brien S Caglioti,, et al. J Clin Microbiol 2008 46 2 499 506 10.1128/JCM.01229-07 18032621
26. Hepatitis B and C in New South Wales prisons: prevalence and risk factors. TG Butler KA Dolan MJ Ferson LM McGuinness PR Brown PW Robertson, Med J Aust 1997 166 3 127 130 9059433
27. Seroprevalence of markers for hepatitis B, C and G in male and female prisoners - NSW, 1996. T Butler J Spencer J Cui K Vickery J Zou J Kaldor, ANZJ Public Health 1999 23 4 377 384
28. Team RDC (Ed.), R: A Language and Environment for Statistical Computing Vienna, Austria: R Foundation for Statistical Computing 2009
29. Incidence and risk for acute hepatitis C infection during imprisonment in Australia. K Dolan S Teutsch N Scheuer M Levy W Rawlinson J Kaldor A Lloyd P Haber, Eur J Epidemiol 2010 25 2 143 148 10.1007/s10654-009-9421-0 20084429
30. High hepatitis C virus prevalence and incidence among Canadian intravenous drug users. E Roy M Alary C Morissette P Leclerc JF Boudreau R Parent J Rochefort C Claessens Surv UDIWG, Int J STD & AIDS 2007 18 1 23 27
31. High hepatitis C incidence in new injecting drug users: a policy failure? L Maher J Li B Jalaludin K Chant J Kaldor, ANZJ Public Health 2007 31 30 35 (Pubitemid 46380631)
32. Hepatitis C virus infection among injection drug users: survival analysis of time to seroconversion. H Hagan H Thiede DC Des Jarlais, Epidemiol 2004 15 5 543 549 10.1097/01.ede.0000135170.54913.9d (Pubitemid 40416907)
33. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. LE Thorpe LJ Ouellet R Hershow SL Bailey IT Williams J Williamson ER Monterroso RS Garfein, Am J Epidemiol 2002 155 7 645 653 10.1093/aje/155.7.645 11914192
34. A literature review of international implementation of opioid substitution treatment in prisons: equivalence of care? S Larney K Dolan, Eur Addiction Res 2009 15 107 112 10.1159/000199046
35. Transmission of hepatitis C virus but not human immunodeficiency virus type 1 following sharing of cleaned injecting equipment. NJ Bodsworth M Robertson J Kaldor, Genitourinary Med 1994 70 3 206 207
36. Transmission of hepatitis C within Australian prisons. PS Haber SJ Parsons SE Harper PA White WD Rawlinson AR Lloyd, Med J Aust 1999 171 1 31 33 10451669
37. Does bleach disinfection of syringes protect against hepatitis C infection among young adult injection drug users? F Kapadia D Vlahov DC Des Jarlais SA Strathdee L Ouellet P Kerndt EEV Morse I Williams RS Garfein Second Collaborative Injection Drug User Study G, Epidemiol 2002 13 6 738 741 10.1097/00001648-200211000-00023 (Pubitemid 44698483)
38. A review of the evidence for the effectiveness of primary prevention interventions for hepatitis C among injecting drug users. NM Wright CN Tompkins, Harm Reduct J 2006 3 27 10.1186/1477-7517-3-27 16956393